VIGNOZZI, LINDA
 Distribuzione geografica
Continente #
NA - Nord America 9.841
EU - Europa 5.142
AS - Asia 626
AF - Africa 18
SA - Sud America 13
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.643
Nazione #
US - Stati Uniti d'America 9.809
PL - Polonia 1.336
IT - Italia 1.299
IE - Irlanda 898
SE - Svezia 632
HK - Hong Kong 194
AT - Austria 173
CH - Svizzera 149
CN - Cina 147
DE - Germania 129
UA - Ucraina 123
FI - Finlandia 120
JO - Giordania 119
GB - Regno Unito 113
BE - Belgio 66
VN - Vietnam 52
TR - Turchia 47
CA - Canada 29
SG - Singapore 29
ES - Italia 25
IN - India 18
FR - Francia 17
NL - Olanda 16
RO - Romania 15
RU - Federazione Russa 14
KR - Corea 7
BR - Brasile 6
SC - Seychelles 6
ZA - Sudafrica 5
JP - Giappone 4
NG - Nigeria 4
IR - Iran 3
MU - Mauritius 3
MX - Messico 3
PH - Filippine 3
AR - Argentina 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
EE - Estonia 2
HR - Croazia 2
MK - Macedonia 2
TM - Turkmenistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
GR - Grecia 1
ID - Indonesia 1
LT - Lituania 1
NO - Norvegia 1
PE - Perù 1
SM - San Marino 1
Totale 15.643
Città #
Fairfield 1.725
Warsaw 1.334
Chandler 925
Dublin 894
Ashburn 851
Woodbridge 793
Houston 721
Seattle 712
Cambridge 631
Wilmington 562
Altamura 367
Lawrence 364
Ann Arbor 252
Princeton 242
Jacksonville 210
Florence 197
Bern 147
Boston 145
Vienna 135
San Diego 128
Buffalo 120
Medford 111
Beijing 105
Boardman 85
Rome 66
Brussels 65
Milan 63
Falls Church 61
Dong Ket 46
Redwood City 43
Norwalk 36
London 31
Hillsboro 30
Izmir 28
Barcelona 24
Dearborn 24
Andover 21
Toronto 17
Detroit 14
Salerno 14
Bologna 13
Redmond 12
Palermo 11
Verona 10
Bremen 9
Guangzhou 9
Trieste 9
Auburn Hills 8
Chennai 8
Istanbul 7
Laurel 7
Lucca 7
Marciano della Chiana 7
Bari 6
Camparada 6
Fontebuona 6
Frankfurt Am Main 6
Ottawa 6
Phoenix 6
Prescot 6
Cape Town 5
Fiesole 5
Pistoia 5
Saint Petersburg 5
Voghera 5
Washington 5
Buttapietra 4
Castelliri 4
Chiswick 4
Hangzhou 4
Hefei 4
Hounslow 4
Los Angeles 4
Messina 4
New Haven 4
Paris 4
Perugia 4
Syracuse 4
Urbino 4
Yreka 4
Ankara 3
Boulder 3
Capaccio 3
Carmignano 3
Carrara 3
Central 3
Forlì 3
Formigine 3
Helsinki 3
La Spezia 3
Liscate 3
Molinella 3
Naples 3
New Bedfont 3
Nieuw-Vennep 3
Pescara 3
San Francisco 3
Seongnam 3
São Paulo 3
Tappahannock 3
Totale 12.644
Nome #
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 382
Metabolic syndrome and lower urinary tract symptoms: the role of inflammation 223
Negative Effects of High Glucose Exposure in Human Gonadotropin-Releasing Hormone Neurons 216
Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit. 205
Benign Prostatic Hyperplasia: A New Metabolic Disease of the Aging Male and Its Correlates with Sexual Dysfunctions 193
Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study. 175
THE USE OF TADALAFIL TO TREAT LOWER URINARY TRACT SYMPTOMS AND ERECTILE DYSFUNCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA: A SYSTEMATIC REVIEW 167
Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study 155
Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis. 154
Meta-analysis of metabolic syndrome and prostate cancer 149
INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function 147
Androgens regulate Phosphodiesterase type 5 expression and functional activity in corpora cavernosa 145
Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause. 139
Acute effects on human sperm exposed in vitro to cadmium chloride and diisoutyl-phthalate 124
Insight on the intracrinology of menopause: androgen production within the human vagina 120
Differential Effects of Testosterone and Estradiol on Clitoral Function: An Experimental Study in Rats 118
Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension. 115
Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men 114
METABOLIC SYNDROME-ASSOCIATED SPERM ALTERATIONS IN AN EXPERIMENTAL RABBIT MODEL: RELATION WITH METABOLIC PROFILE, TESTIS AND EPIDIDYMIS GENE EXPRESSION AND EFFECT OF TAMOXIFEN TREATMENT 113
Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit. 112
Tumor Necrosis Factor α Impairs Kisspeptin Signaling in Human Gonadotropin-Releasing Hormone Primary Neurons 109
A Randomized, Placebo-Controlled Study to Assess Safety andEfficacy of Vardenafil 10 mg and Tamsulosin 0.4 mg vs. Tamsulosin 0.4 mg Alone in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. 107
Klinefelter syndrome: cardiovascular abnormalities and metabolic disorders. 106
Identification, localization and functional in vitro and in vivo activity of oxytocin receptor in the rat penis. 104
Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial. 104
Cardiometabolic Risk and Female Sexuality: Focus on Clitoral Vascular Resistance 103
The non-aromatizable androgen dihydrotestosterone (DHT) facilitates sexual behavior in ovariectomized female rats primed with estradiol. 102
Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia? 101
Testosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model. 101
Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis 100
The Impact of Central Obesity on Storage Luts and Urinary Incontinence After Prostatic Surgery 98
5α-Reductase-2 deficiency: is gender assignment recommended in infancy? Two case-reports and review of the literature 98
Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. 98
Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbits. 98
Psychosexual Correlates of Unwanted Sexual Experiences in Women Consulting for Female Sexual Dysfunction According to Their Timing Across the Life Span 96
Clinical characteristics of men complaining of premature ejaculation together with erectile dysfunction: a cross-sectional study. 95
Identification, characterization and biological activity of oxytocin receptor in the developing human penis. 94
Acute vardenafil administration improves bladder oxygenation in spontaneously hypertensive rats. 94
Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes. 93
Klinefelter's Syndrome: A Clinical and Therapeutical Update 93
Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: A role for GPR30/GPER? 92
Risks and benefits of late onset hypogonadism treatment: an expert opinion 92
Testosterone, cardiovascular disease and the metabolic syndrome. 91
Validation of a Visual Analogue Scale to measure the subjective perception of orgasmic intensity in females: The Orgasmometer-F 91
Beneficial effects of bile acid receptor agonists in pulmonary disease models. 91
Benign prostatic hyperplasia: a new metabolic disease? 90
Farnesoid X Receptor Activation Improves Erectile Function in Animal Models of Metabolic Syndrome and Diabetes. 90
Treatment of Functional Hypogonadism Besides Pharmacological Substitution 90
The vitamin D receptor agonist elocalcitol upregulates L-type calcium channel activity in human and rat bladder 89
Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. 88
Brain Sex Differences Related to Gender Identity Development: Genes or Hormones? 88
Hormonal Treatment Effect on Sexual Distress in Transgender Persons: 2-Year Follow-Up Data 88
Anti-inflammatory effects of androgens in the human vagina 88
Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. 87
Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements. 87
Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome 86
Anti-inflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells. 86
Which patients with sexual dysfunction are suitable for testosterone replacement therapy? 85
FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS. 84
Changes in sex hormone levels after radical prostatectomy: Results of a longitudinal cohort study. 84
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. 84
Management of benign prostatic hyperplasia: role of phosphodiesterase-5 inhibitors. 84
Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway. 83
Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model 83
Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility 82
Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome. 82
A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. 82
Endocrine control of ejaculation 82
Oxytocin mediates the estrogen-dependent contractile activity of endothelin-1 in human and rabbit epididymis. 82
Sex steroids and leptin regulate the "first Kiss" (KiSS 1/G-protein-coupled receptor 54 system) in human gonadotropin-releasing-hormone-secreting neuroblasts. 82
Characterization and functional role of androgen-dependent PDE5 activity in the bladder. 81
Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation. 81
Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit. 81
Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. 80
Role of Sexuality in the Outcome of Anorexia Nervosa and Bulimia Nervosa: A 3-Year Follow-Up Study 80
Nomegestrol acetate/17beta-estradiol does not negatively alter the vascular resistance of clitoral arteries: a prospective, exploratory study 80
Peripheral regulatory mechanisms in erection 80
Cardiovascular risk engines can help in selecting patients to be evaluated by dynamic penile color doppler ultrasound. 80
PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH 79
Testosterone protects from metabolic syndrome-associated prostate inflammation: An experimental study in rabbit 79
Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat. 78
BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder. 78
Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial 78
Testosterone therapy in men with Crohn's disease improves the clinical course of the disease: data from long-term observational registry study. 78
Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model. 78
Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells (Erratum) 78
Neural Correlates of Gender Face Perception in Transgender People 78
Outcome of Medical and Psychosexual Interventions for Vaginismus: A Systematic Review and Meta-Analysis. 77
Emerging medication for the treatment of male hypogonadism. 76
CHILDHOOD SEXUAL ABUSE MODERATES THE RELATIONSHIP BETWEEN SEXUAL FUNCTIONING AND EATING DISORDER PSYCHOPATHOLOGY IN ANOREXIA NERVOSA AND BULIMIA NERVOSA: A 1-YEAR-FOLLOW-UP STUDY. 76
Sperm recovery and ICSI outcomes in Klinefelter syndrome: a systematic review and meta-analysis. 76
Human prostatic urethra expresses Vitamin D receptor and responds to Vitamin D receptor ligation. 76
Serum PSA as a Predictor of Testosterone Deficiency. 75
Dihydrotestosterone and leptin regulate gonadotropin-releasing hormone (GnRH) expression and secretion in human GnRH-secreting neuroblasts. 74
Anorectic and Bulimic Patients Suffer from Relevant Sexual Dysfunctions. 74
Bringing the body of the iceberg to the surface: the Female Sexual Dysfunction Index-6 (FSDI-6) in the screening of female sexual dysfunction 74
Estrogen mediates metabolic syndrome-induced erectile dysfunction: a study in the rabbit. 74
Clinical and therapeutic aspects of Klinefelter's Syndrome: sexual function. 73
Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation. 73
Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats. 72
Totale 10.170
Categoria #
all - tutte 45.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.365 0 0 0 0 0 23 36 47 41 252 504 462
2019/20203.480 250 198 75 262 420 402 418 431 387 233 313 91
2020/20212.580 196 221 134 412 127 257 139 183 244 348 161 158
2021/20222.019 85 199 301 61 55 77 73 235 96 81 316 440
2022/20234.590 385 991 168 267 290 707 635 254 403 115 138 237
2023/20241.020 92 186 341 146 233 22 0 0 0 0 0 0
Totale 16.237